Juno

vs

other labs

Juno vs other labs

other labs
JUNO
25,007 embryos analyzed. %transferable per informative embryo
(mosaic are included in the Juno column)

REDUCTION IN

MOSAIC

EMBRYOS

The enhanced accuracy of PGT[A]Seq prevents viable embryos from being incorrectly classified mosaic.
0 %
MORE EUPLOID EMBRYOS
+ 0
EXTRA EMBRYOS reported for transfer from a dataset of 25,007 embryos derived from 15 different IVF clinics
+ 0
EMBRYOS AVAILABLE to Transfer

Know your
Clinical Rates

1.5%

NON
INFORMATIVE

EMBRYOS

Juno PGT[A]Seq

Fewer mosaic embryos reported

A high-profile study involving the most widely used PGT[A]Seq method, performed at nine genetic laboratories in four different countries, reported a high incidence of mosaicism (Munne et al., 2019). 

Juno’s PGT[A]Seq method is highly validated for the detection of aneuploidy and mosaicism in embryo biopsy specimens. PGT[A]Seq avoids the incorrect classification of potentially viable embryos as “Mosaic” or “abnormal”.

900 828 420